ON Semiconductor Selected by CVRx, Inc. for Advanced Implantable Device Used in the Treatment of Hypertension

PHOENIX--(BUSINESS WIRE)-- ON Semiconductor (Nasdaq: ONNN), a premier supplier of high-performance silicon solutions for energy efficient electronics, announced today that CVRx, a market-leading developer of proprietary active implantable technology to treat high blood pressure, is using its technology and manufacturing services. CVRx recently launched the Barostim neo™ – the company’s second-generation implantable anti-hypertensive barostimulation device – in Europe.